Artal Group’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-511,784	Closed	-$11.5M	–	128
2023 Q1	$11.5M	Buy	511,784 +11,784	+2%	+$265K	0.68%	36
2022 Q4	$10.5M	Buy	+500,000	New	+$10.5M	0.59%	38